Primary Insights: now with a more clinical focus

You see a broad mix of patient types and treat a wide range of conditions, requiring information on a case-by-case, patient-by-patient basis.

That’s why Quest Diagnostics has updated Primary Insights to provide you with clinical insights that can help you support organizational guidelines for all patient, visit, and condition types. You can also still access resources for improved practice management and patient engagement.
Subscribe today
to Primary Insights

Always get the clinical insights most relevant to you and your patients.
 
 
This website uses cookies for improvement of quality and user experience. By continuing to use the site, you confirm your awareness and acceptance of our use of cookies. For more information or to opt out of the use of cookies, see our Cookies Notice.

 

Get a better grip on rheumatoid arthritis

You enter the exam room and greet your patient, a 38-year-old mother of three, including a 1-year-old boy she has with her today. She’s asked to see you because she’s been experiencing pain and tenderness in her wrist joints for several months. She had rationalized the pain by attributing it to toting her baby around and “approaching 40,” but her husband urged her to have it checked out. Learn more

Sensitivity or allergy? Know more with allergen component testing.

You’ve seen it many times before: a patient presents with a possible food allergy. He points to a recent reaction—itchiness and vomiting—after eating a cookie containing Brazil nuts, his first encounter. Now he wants to know whether he’s sensitive to the nut, allergic, or if it is something else altogether. Learn more

Practice advancement: a multimarker strategy for CVD risk stratification

How many patients are you treating for heart disease or its warning signs, e.g., hypertension or hyperlipidemia? You probably know the number or have a general sense. Now, here’s the harder question: how many of those patients are at higher risk of their disease progressing or of having a heart attack or stroke? In other words, which patients should you be monitoring more closely?

Learn more

Does your patient have a lipid problem you can’t see?
Does your patient have a lipid problem you can’t see?

Does your patient have a lipid problem you can’t see?

For years, the traditional lipid panel has been the standard of care for risk assessment and monitoring cardiovascular disease (CVD) or dyslipidemia, with low-density lipoprotein cholesterol (LDL-C) levels being the main target of treatment. However, while a traditional lipid panel measures the amount of cholesterol and triglycerides within lipoprotein particles, additional diagnostic tests can help identify other risk factors, including the number of atherogenic particles and the size of these particles.

Learn more

Is your seemingly healthy patient at risk for CVD?


Model used for illustrative purposes.

A previous Primary Insights post discussed the response-to-injury hypothesis in cardiovascular disease (CVD). The events leading to CVD are thought to begin with an injury to the arterial wall. Risk factors like smoking, hypertension, and diabetes can injure the arterial wall, making it more susceptible to penetration and accumulation of excess lipids. Learn more

Inflammatory markers: offering a closer look at cardiovascular risk

It’s an all-too familiar story: you learn that your patient was brought to the emergency department with symptoms of heart attack—the same patient who recently had normal cholesterol and triglyceride results at the time of their annual wellness visit. Could this heart attack have been prevented with additional testing?

Learn more